To systematically evaluate the prognostic value of the T-cell–infiltrating levels, chemokine activity, and the two driver genes, TP53 and MAX, in HCC, we tested their association with OS in TCGA, GSE14520, and CPTAC cohorts (Gao et al., 2019). The gene discussed is TP53; the disease is hepatocellular carcinoma.